Happi Staff06.18.20
The Australian Department of Therapeutic Goods Administration (TGA) has announced that it is taking action to ensure the effectiveness of some sunscreens on the Australian market that may be affected by potentially fraudulent laboratory testing reported in the US, according to the Personal Care Product Council. To ensure that there is minimal impact, the TGA is implementing additional interim regulatory measures as part of its post-marketing compliance monitoring activities. These will ensure that potentially affected products can continue to be supplied in Australia until an independent laboratory can conduct further SPF testing.
For more information, see the TGA press release.
For more information, see the TGA press release.
